IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study.

Jason M Scovell,Mark Stovsky,Alan Partin,Yair Lotan,Jack Baniel,Martin Dineen,Jason Hafron,Kannan Manickam,Marc Pliskin,Matthew Wagner,Aimee Kestranek,Eric A Klein

Urology（2023）

引用 0|浏览15

暂无评分

摘要

The performance of IsoPSA for detecting any prostate cancer and clinically actionable prostate cancer is unaffected by commonly used medications (5-ARI and α-blockers) for symptoms of benign prostatic hyperplasia.

查看译文

关键词

biomarker,early detection of cancer,prostate neoplasm,prostatic hyperplasia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要